BIO vs TBLAW · rev $651.0M vs rev $1.91B
BIO (BIO) versus Taboola.com Ltd. Warrant (TBLAW) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Taboola.com Ltd. Warrant (TBLAW) common stock listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported TBLAW revenue for 2025-12-31 was $1.91B. Net income was $42.3M. Revenue was up 8.3% from 2024-12-31 to 2025-12-31.
BIO currently screens at market cap $0.
Not investment advice. Open the BIO and TBLAW stock pages for the full models.
Not investment advice.